Giles A - Search Results

1

The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.

Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I. Verbruggen B, et al. Among authors: giles a. Thromb Haemost. 2001 Dec;86(6):1435-9. Thromb Haemost. 2001. PMID: 11776311

2

A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.

Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I. Giles AR, et al. Thromb Haemost. 1998 Apr;79(4):872-5. Thromb Haemost. 1998. PMID: 9569207

3

A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay.

Verbruggen B, van Heerde W, Novákovà I, Lillicrap D, Giles A. Verbruggen B, et al. Among authors: giles a. Thromb Haemost. 2002 Aug;88(2):362-4. Thromb Haemost. 2002. PMID: 12195715 No abstract available.

4

Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.

Samis JA, Garrett M, Manuel RP, Nesheim ME, Giles AR. Samis JA, et al. Among authors: giles ar. Blood. 1997 Aug 1;90(3):1065-74. Blood. 1997. PMID: 9242537 Free article.

5

Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.

Ribau JC, Samis JA, Senis YA, Maurice DH, Giles AR, DeReske M, Absher PM, Hatton MW, Richardson M. Ribau JC, et al. Among authors: giles ar. Atherosclerosis. 2000 Apr;149(2):331-42. doi: 10.1016/s0021-9150(99)00344-5. Atherosclerosis. 2000. PMID: 10729383

6

Proteolytic processing of human coagulation factor IX by plasmin.

Samis JA, Ramsey GD, Walker JB, Nesheim ME, Giles AR. Samis JA, et al. Among authors: giles ar. Blood. 2000 Feb 1;95(3):943-51. Blood. 2000. PMID: 10648407 Free article.

7

The role of factor VII in haemostasis: infusion studies of factor VIIa in a canine model of factor VIII deficiency.

Mertens K, Briët E, Giles AR. Mertens K, et al. Among authors: giles ar. Thromb Haemost. 1990 Aug 13;64(1):138-44. Thromb Haemost. 1990. PMID: 2274919

8

Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.

Samis JA, Kam E, Nesheim ME, Giles AR. Samis JA, et al. Among authors: giles ar. Blood. 1998 Aug 15;92(4):1287-96. Blood. 1998. PMID: 9694717 Free article.

9

The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.

Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, Giles AR, Yoshioka A. Matsumoto T, et al. Among authors: giles ar. J Thromb Haemost. 2006 Feb;4(2):377-84. doi: 10.1111/j.1538-7836.2006.01730.x. J Thromb Haemost. 2006. PMID: 16420569 Free article.

10

The canine factor VIII cDNA and 5' flanking sequence.

Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, Giles A, Lillicrap D. Cameron C, et al. Among authors: giles a. Thromb Haemost. 1998 Feb;79(2):317-22. Thromb Haemost. 1998. PMID: 9493583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters